FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline Amyvid is the first and only radioactive diagnostic ...

INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced they received a positive opinion ...

Company Remains Committed to Alzheimer's Disease Research and Development to Bring Innovative New Products to Patients Who Need Them Most Amyvid is a beta-amyloid imaging agent for use in adults with ...

Eli Lilly and Company LLY and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, announced today that Amyvid (Florbetapir F 18 Injection) has received marketing authorization from ...

The Centers for Medicare and Medicaid Services (CMS) is pursuing a National Coverage Determination (NCD) for monoclonal antibodies that clear amyloid beta plaque from the brain, such as aducanumab ...

INDIANAPOLIS, July 8, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with ...

- Study to further assess the utility of amyloid brain PET scans for Alzheimer's Disease and other causes of cognitive decline INDIANAPOLIS, Dec. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: ...

Essentia Health in Duluth now has a new tool to help diagnose Alzheimer’s, and it’s the first of its kind in the Northland. The amyloid PET Scan machine helps detect signs of the plaques that build up ...

A Centers for Medicare & Medicaid Services advisory panel has questioned whether there's enough evidence that amyloid PET imaging can improve health outcomes in people with early cognitive dysfunction ...

Amyvid™ (Florbetapir F 18 Injection) Approved in European Union for Use in Patients With Cognitive Impairment Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Impairment ...